Vol 5, No 4 (2004): Practical Diabetology
Research paper
Published online: 2004-07-21
Intensification of insulin therapy in Poland. Basic parameters of metabolic control and treatment satisfaction ó results of a large trial of patients with type 2 diabetes
Diabetologia Praktyczna 2004;5(4):173-182.
Abstract
INTRODUCTION. The aim of the study was to establish the profile of patients
who undergo intensification of insulin therapy In Poland and what is the efficacy
of that intervention. Moreover the study was aimed at finding out the interaction
between arbitrary assumed typology of patients and acceptability and effects of
insulin therapy.
MATERIALS AND METHODS. During year 2002, 5737 patients with type 2 diabetes took part in the study. HbA1c, demographics, current diabetes complications and assumed typology of patients were registered. In 4 weeks interval fasting glycemia, postprandial morning glycemia and diabetes treatment satisfaction questionnaire were noted.
RESULTS. It appears that non-active and passive persons are 62% of all patients. Most of the subjects are treated with Oral Hypoglycemic Agents (OHA) — 72.8%. Insulin therapy is being intensified in 8.3 years after diagnosis and mean HbA1c at this moment is 9.10%. Non-active and passive patients hale insulin therapy intensified at slightly higher HbA1c values. 60% of the subjects had late diabetes complications. Treatment satisfaction (all parameters) was independent from treatment method and was in general higher after intensification. Higher satisfaction tendency was observed in active and innovative groups.
MATERIALS AND METHODS. During year 2002, 5737 patients with type 2 diabetes took part in the study. HbA1c, demographics, current diabetes complications and assumed typology of patients were registered. In 4 weeks interval fasting glycemia, postprandial morning glycemia and diabetes treatment satisfaction questionnaire were noted.
RESULTS. It appears that non-active and passive persons are 62% of all patients. Most of the subjects are treated with Oral Hypoglycemic Agents (OHA) — 72.8%. Insulin therapy is being intensified in 8.3 years after diagnosis and mean HbA1c at this moment is 9.10%. Non-active and passive patients hale insulin therapy intensified at slightly higher HbA1c values. 60% of the subjects had late diabetes complications. Treatment satisfaction (all parameters) was independent from treatment method and was in general higher after intensification. Higher satisfaction tendency was observed in active and innovative groups.
Keywords: insulin therapydiabetic controltreatment satisfactiontype 2 diabetes